Free Newsletter
Genentech chooses Google for Outlook
Genentech says it sees Google as a strategic IT platform, reports ChannelWeb. The big biopharma moved its 15,000 employees to Google Apps last year, despite seeing user preference for Outlook as hurdle. Genentech credits Google's MAPI-based synchronizer for overcoming earlier performance issues compared with Microsoft Exchange. Article
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: